Serina Therapeutics SER
NYSE SER
$1.51 +0.07 (+4.86%)
At close: Nov 11, 2026 · 4:00 PM EST

Serina Therapeutics (SER) Price to Earnings (2023)

Updated

Serina Therapeutics' (SER) Price to Earnings was 2.82 for Q4 2023, down 99.5% from the prior quarter.

Analysis

Serina Therapeutics (SER) Price to Earnings (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Serina Therapeutics 23.59 Mn -35.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 2.82
Sep 30, 2023 608.47
API Access

Serina Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=SER&period=max&api_key=YOUR_API_KEY